BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,395,868 | -19.3% | 266,744 | +1.6% | 0.00% | 0.0% |
| Q2 2023 | $16,597,372 | +40.0% | 262,617 | -0.4% | 0.00% | 0.0% |
| Q1 2023 | $11,857,430 | +3.1% | 263,557 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $11,501,702 | -32.8% | 262,536 | +1.1% | 0.00% | -25.0% |
| Q3 2022 | $17,115,000 | +41.6% | 259,747 | +8.6% | 0.00% | +33.3% |
| Q2 2022 | $12,085,000 | -23.5% | 239,285 | -3.2% | 0.00% | 0.0% |
| Q1 2022 | $15,795,000 | -77.1% | 247,261 | -61.6% | 0.00% | -75.0% |
| Q4 2021 | $68,899,000 | -2.4% | 643,257 | -6.4% | 0.01% | -14.3% |
| Q3 2021 | $70,618,000 | +15.5% | 686,886 | -1.2% | 0.01% | +16.7% |
| Q2 2021 | $61,164,000 | -6.3% | 695,347 | +3.6% | 0.01% | -7.7% |
| Q1 2021 | $65,278,000 | +15.8% | 671,370 | +33.6% | 0.01% | +8.3% |
| Q4 2020 | $56,360,000 | +29.0% | 502,536 | +6.6% | 0.01% | +9.1% |
| Q3 2020 | $43,689,000 | +23.8% | 471,301 | +4.2% | 0.01% | +22.2% |
| Q2 2020 | $35,293,000 | +77.1% | 452,467 | +32.8% | 0.01% | +28.6% |
| Q1 2020 | $19,926,000 | +17.6% | 340,707 | +61.1% | 0.01% | +75.0% |
| Q4 2019 | $16,941,000 | +11.0% | 211,465 | +1.8% | 0.00% | 0.0% |
| Q3 2019 | $15,260,000 | -24.2% | 207,697 | -2.7% | 0.00% | -20.0% |
| Q2 2019 | $20,128,000 | +29.5% | 213,373 | +9.9% | 0.01% | +25.0% |
| Q1 2019 | $15,544,000 | +58.3% | 194,167 | +6.6% | 0.00% | +33.3% |
| Q4 2018 | $9,817,000 | -34.5% | 182,119 | -5.2% | 0.00% | -25.0% |
| Q3 2018 | $14,995,000 | +23.0% | 192,095 | +0.0% | 0.00% | +33.3% |
| Q2 2018 | $12,193,000 | -35.0% | 192,082 | -6.2% | 0.00% | -40.0% |
| Q1 2018 | $18,769,000 | +28.3% | 204,673 | +5.5% | 0.01% | +25.0% |
| Q4 2017 | $14,624,000 | +19.2% | 193,937 | +10.2% | 0.00% | +33.3% |
| Q3 2017 | $12,264,000 | +38.5% | 176,029 | +0.8% | 0.00% | +50.0% |
| Q2 2017 | $8,853,000 | +83.6% | 174,703 | +44.9% | 0.00% | +100.0% |
| Q1 2017 | $4,822,000 | +83.9% | 120,568 | +29.0% | 0.00% | 0.0% |
| Q4 2016 | $2,622,000 | +2.7% | 93,473 | +8.8% | 0.00% | 0.0% |
| Q3 2016 | $2,553,000 | +78.2% | 85,922 | +21.4% | 0.00% | – |
| Q2 2016 | $1,433,000 | +67.2% | 70,750 | +48.9% | 0.00% | – |
| Q1 2016 | $857,000 | -19.5% | 47,506 | +17.5% | 0.00% | – |
| Q4 2015 | $1,064,000 | +81.3% | 40,417 | +46.8% | 0.00% | – |
| Q3 2015 | $587,000 | -32.8% | 27,530 | -16.6% | 0.00% | – |
| Q2 2015 | $874,000 | – | 33,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |